Special Issue "Advancement in Design and Synthesis of Novel Drug"
Deadline for manuscript submissions: 30 November 2021.
The development of a novel medicine starts when researchers learn of a biological target, such as protein, gene, receptor etc., which plays a critical role in diseases such as cancers, diabetes, or neurological disorders. This Special Issue will cover the discovery and development of a variety of novel agents. Here, we will cover the discovery and development of entirely new agents, those with a mode of action different from already approved medicines and intended for clinical translations. Our aim is to publish the recent advancement in the area of drug discovery and development. One overall theme of our Special Issue is to report the preclinical or clinical studies of novel agents and understand their designing, synthesis, and characterization. This Special Issue will facilitate the translation of new agents to the next level. As editors of the journal, we encourage the submission of research reports that provide data relevant to this Special Issue.
Dr. Manoj K. Pandey
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medicinal chemistry
- drug design
- drug development
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Type of the paper: Review
Tentative title: Phytochemicals in the Prevention of Metastasis in Lung Cancer
Authors: Christina Campbell, David Cline, Kartick C Pramanik
Affiliations: Kentucky College of Osteopathic Medicine, University Pikeville, KY, 41501
Lung cancer has the highest mortality rate compared to any other cancer due to it being diagnosed in the very late stages. During the late stages of lung cancer, metastasis is often seen making surgical resection extremely difficult. Chemotherapy, a common method of cancer treatment, has also been found ineffective due to the patient becoming resistant. Dietary agents such as phytochemicals have shown promising results in the prevention of lung cancer as well as the metastasis process. In this review article, we have investigated the novel mechanisms of multiple promising phytochemicals in their prevention of lung cancer metastasis.
Submission Date: 1st April, 2021